Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study

Authors: Su-Pen Yang, Yin-Yin Chen, Han-Shui Hsu, Fu-Der Wang, Liang-yu Chen, Chang-Phone Fung

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

The incidence of fungal healthcare-associated infection (HAI) has increased in a major teaching hospital in the northern part of Taiwan over the past decade, especially in the intensive care units (ICUs). The purpose of this study was to determine the factors that were responsible for the outbreak and trend in the ICU.

Methods

Surveillance fungal cultures were obtained from “sterile” objects, antiseptic solutions, environment of infected patients and hands of medical personnel. Risk factors for comparison included age, gender, admission service, and total length of stay in the ICU, Acute Physiology and Chronic Health Evaluation (APACHE) II scores at admission to the ICU, main diagnosis on ICU admission, use of invasive devices, receipt of hemodialysis, total parenteral nutrition (TPN) use, history of antibiotic therapy before HAI or during ICU stay in no HAI group, and ICU discharge status (ie, dead or alive). Univariable analysis followed by multiple logistic regression analysis was performed to identify the independent risk factors for ICU fungal HAIs and ICU mortality.

Results

There was a significant trend in ICU fungal HAIs from 1998 to 2009 (P < 0.001). A total of 516 episodes of ICU fungal HAIs were identified; the rates of various infections were urinary tract infection (UTI) (54.8%), blood stream infection (BSI) (30.6%), surgical site infection (SSI) (6.6%), pneumonia (4.5%), other sites (3.5%). The fungi identified were: yeasts (54.8%), Candida albicans (27.3%), Candida tropicalis (6.6%), Candida glabrata (6.6%), Candida parapsilosis (1.9%), Candida species (0.8%), and other fungi (1.9%). Candida albicans accounted for 63% of all Candida species. Yeasts were found in the environment of more heavily infected patients. The independent risk factors (P < 0.05) of developing ICU fungal HAIs from all sites were TPN use, sepsis, surgical patients, mechanical ventilation and an indwelling urinary catheter. The independent risk factors for ICU fungal UTI included TPN use, mechanical ventilation and an indwelling urinary catheter. The independent risk factors for ICU fungal BSI included TPN use, sepsis, and higher APACHE II score. The independent risk factors for ICU fungal pneumonia included TPN use, surgical patients. The independent risk factors for ICU fungal SSI included surgical patients, and TPN use. The odds ratios of TPN use in various infection types ranged from 3.51 to 8.82. The risk of mortality in patients with ICU fungal HAIs was over 2 times that of patients without ICU HAIs in the multiple logistic regression analysis (P < 0.001).

Conclusions

There was a secular trend of an increasing number of fungal HAIs in our ICU over the past decade. Patients with ICU fungal HAIs had a significantly higher mortality rate than did patients without ICU HAIs. Total parenteral nutrition was a significant risk factor for all types of ICU fungal HAIs, and its use should be monitored closely.
Appendix
Available only for authorised users
Literature
1.
go back to reference Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003, 348 (16): 1546-1554.CrossRefPubMed Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003, 348 (16): 1546-1554.CrossRefPubMed
2.
go back to reference Lamagni TL, Evans BG, Shigematsu M, Johnson EM: Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990–9). Epidemiol Infect. 2001, 126 (3): 397-414.CrossRefPubMedPubMedCentral Lamagni TL, Evans BG, Shigematsu M, Johnson EM: Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990–9). Epidemiol Infect. 2001, 126 (3): 397-414.CrossRefPubMedPubMedCentral
3.
go back to reference Arendrup MC, Bruun B, Christensen JJ, Fuursted K, Johansen HK, Kjaeldgaard P, Knudsen JD, Kristensen L, Moller J, Nielsen L, et al: National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol. 2011, 49 (1): 325-334.CrossRefPubMed Arendrup MC, Bruun B, Christensen JJ, Fuursted K, Johansen HK, Kjaeldgaard P, Knudsen JD, Kristensen L, Moller J, Nielsen L, et al: National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol. 2011, 49 (1): 325-334.CrossRefPubMed
4.
go back to reference Karlowsky JA, Zhanel GG, Klym KA, Hoban DJ, Kabani AM: Candidemia in a Canadian tertiary care hospital from 1976 to 1996. Diagn Microbiol Infect Dis. 1997, 29 (1): 5-9.CrossRefPubMed Karlowsky JA, Zhanel GG, Klym KA, Hoban DJ, Kabani AM: Candidemia in a Canadian tertiary care hospital from 1976 to 1996. Diagn Microbiol Infect Dis. 1997, 29 (1): 5-9.CrossRefPubMed
5.
go back to reference Chen YC, Chang SC, Sun CC, Yang LS, Hsieh WC, Luh KT: Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. Infect Control Hosp Epidemiol. 1997, 18 (5): 369-375.CrossRefPubMed Chen YC, Chang SC, Sun CC, Yang LS, Hsieh WC, Luh KT: Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. Infect Control Hosp Epidemiol. 1997, 18 (5): 369-375.CrossRefPubMed
6.
go back to reference Beck-Sague C, Jarvis WR: Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. National Nosocomial Infections Surveillance System. J Infect Dis. 1993, 167 (5): 1247-1251.CrossRefPubMed Beck-Sague C, Jarvis WR: Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. National Nosocomial Infections Surveillance System. J Infect Dis. 1993, 167 (5): 1247-1251.CrossRefPubMed
7.
go back to reference Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB: Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004, 39 (3): 309-317.CrossRefPubMed Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB: Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004, 39 (3): 309-317.CrossRefPubMed
8.
go back to reference Arendrup MC, Sulim S, Holm A, Nielsen L, Nielsen SD, Knudsen JD, Drenck NE, Christensen JJ, Johansen HK: Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol. 2011, 49 (9): 3300-3308.CrossRefPubMedPubMedCentral Arendrup MC, Sulim S, Holm A, Nielsen L, Nielsen SD, Knudsen JD, Drenck NE, Christensen JJ, Johansen HK: Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol. 2011, 49 (9): 3300-3308.CrossRefPubMedPubMedCentral
9.
go back to reference Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, Rosso R, Pallavicini FB, Viscoli C: Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis. 2006, 6: 21-CrossRefPubMedPubMedCentral Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, Rosso R, Pallavicini FB, Viscoli C: Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis. 2006, 6: 21-CrossRefPubMedPubMedCentral
10.
go back to reference Jarvis WR, Martone WJ: Predominant pathogens in hospital infections. J Antimicrob Chemother. 1992, 29 (Suppl A): 19-24.CrossRefPubMed Jarvis WR, Martone WJ: Predominant pathogens in hospital infections. J Antimicrob Chemother. 1992, 29 (Suppl A): 19-24.CrossRefPubMed
11.
go back to reference Pfaller MA: Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin Infect Dis. 1996, 22 (Suppl 2): S89-S94.CrossRefPubMed Pfaller MA: Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin Infect Dis. 1996, 22 (Suppl 2): S89-S94.CrossRefPubMed
12.
go back to reference Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, Edwards JR, Tolson J, Henderson T, Martone WJ: Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989. National Nosocomial Infections Surveillance System. Am J Med. 1991, 91 (3B): 86S-89S.CrossRefPubMed Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, Edwards JR, Tolson J, Henderson T, Martone WJ: Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989. National Nosocomial Infections Surveillance System. Am J Med. 1991, 91 (3B): 86S-89S.CrossRefPubMed
13.
go back to reference Emori TG, Gaynes RP: An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev. 1993, 6 (4): 428-442.CrossRefPubMedPubMedCentral Emori TG, Gaynes RP: An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev. 1993, 6 (4): 428-442.CrossRefPubMedPubMedCentral
14.
go back to reference Jarvis WR, Edwards JR, Culver DH, Hughes JM, Horan T, Emori TG, Banerjee S, Tolson J, Henderson T, Gaynes RP, et al: Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med. 1991, 91 (3B): 185S-191S.CrossRefPubMed Jarvis WR, Edwards JR, Culver DH, Hughes JM, Horan T, Emori TG, Banerjee S, Tolson J, Henderson T, Gaynes RP, et al: Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med. 1991, 91 (3B): 185S-191S.CrossRefPubMed
15.
go back to reference Richards MJ, Edwards JR, Culver DH, Gaynes RP: Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol. 2000, 21 (8): 510-515.CrossRefPubMed Richards MJ, Edwards JR, Culver DH, Gaynes RP: Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol. 2000, 21 (8): 510-515.CrossRefPubMed
16.
go back to reference Lee CM, Su QX, Chow WH, Wang LS, Wang FD, Wang JT, Leu HS, Chow MY, Chuang YC, Hwang KP, Chen YS, Fang CT, Wu SC, Kuo IT, Chien LR, Yen CC, Tseng SH, Chang SC: Report of Taiwan nosocomial infections surveillance system (TNIS), 2009. Infection Control Journal. 2011, 21 (3): 195-201. Lee CM, Su QX, Chow WH, Wang LS, Wang FD, Wang JT, Leu HS, Chow MY, Chuang YC, Hwang KP, Chen YS, Fang CT, Wu SC, Kuo IT, Chien LR, Yen CC, Tseng SH, Chang SC: Report of Taiwan nosocomial infections surveillance system (TNIS), 2009. Infection Control Journal. 2011, 21 (3): 195-201.
17.
go back to reference Hung CC, Chen YC, Chang SC, Luh KT, Hsieh WC: Nosocomial candidemia in a university hospital in Taiwan. J Formos Med Assoc. 1996, 95 (1): 19-28.PubMed Hung CC, Chen YC, Chang SC, Luh KT, Hsieh WC: Nosocomial candidemia in a university hospital in Taiwan. J Formos Med Assoc. 1996, 95 (1): 19-28.PubMed
18.
go back to reference Chen LY, Liao SY, Kuo SC, Chen SJ, Chen YY, Wang FD, Yang SP, Fung CP: Changes in the incidence of candidaemia during 2000–2008 in a tertiary medical centre in northern Taiwan. J Hosp Infect. 2011, 78 (1): 50-53.CrossRefPubMed Chen LY, Liao SY, Kuo SC, Chen SJ, Chen YY, Wang FD, Yang SP, Fung CP: Changes in the incidence of candidaemia during 2000–2008 in a tertiary medical centre in northern Taiwan. J Hosp Infect. 2011, 78 (1): 50-53.CrossRefPubMed
19.
go back to reference Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988, 16 (3): 128-140.CrossRefPubMed Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988, 16 (3): 128-140.CrossRefPubMed
20.
go back to reference Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG: CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992, 13 (10): 606-608.CrossRefPubMed Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG: CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992, 13 (10): 606-608.CrossRefPubMed
21.
go back to reference Chen YY, Wang FD, Liu CY, Chou P: Incidence rate and variable cost of nosocomial infections in different types of intensive care units. Infect Control Hosp Epidemiol. 2009, 30 (1): 39-46.CrossRefPubMed Chen YY, Wang FD, Liu CY, Chou P: Incidence rate and variable cost of nosocomial infections in different types of intensive care units. Infect Control Hosp Epidemiol. 2009, 30 (1): 39-46.CrossRefPubMed
22.
go back to reference Chen YY, Chen LY, Lin SY, Chou P, Liao SY, Wang FD: Surveillance on secular trends of incidence and mortality for device-associated infection in the intensive care unit setting at a tertiary medical center in Taiwan, 2000–2008: A retrospective observational study. BMC Infect Dis. 2012, 12: 209-CrossRefPubMedPubMedCentral Chen YY, Chen LY, Lin SY, Chou P, Liao SY, Wang FD: Surveillance on secular trends of incidence and mortality for device-associated infection in the intensive care unit setting at a tertiary medical center in Taiwan, 2000–2008: A retrospective observational study. BMC Infect Dis. 2012, 12: 209-CrossRefPubMedPubMedCentral
23.
go back to reference Horan TC, Andrus M, Dudeck MA: CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008, 36 (5): 309-332.CrossRefPubMed Horan TC, Andrus M, Dudeck MA: CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008, 36 (5): 309-332.CrossRefPubMed
24.
go back to reference Nedret Koc A, Kocagoz S, Erdem F, Gunduz Z: Outbreak of nosocomial fungemia caused by Candida glabrata. Mycoses. 2002, 45 (11–12): 470-475.PubMed Nedret Koc A, Kocagoz S, Erdem F, Gunduz Z: Outbreak of nosocomial fungemia caused by Candida glabrata. Mycoses. 2002, 45 (11–12): 470-475.PubMed
25.
go back to reference Zancope-Oliveira RM, James MJ, Derossi AP, Sampaio JL, Muniz MM, Li RK, Nascimento AS, Peralta JM, Reiss E: Strain characterization of Candida parapsilosis fungemia by molecular typing methods. Eur J Clin Microbiol Infect Dis. 2000, 19 (7): 514-520.CrossRefPubMed Zancope-Oliveira RM, James MJ, Derossi AP, Sampaio JL, Muniz MM, Li RK, Nascimento AS, Peralta JM, Reiss E: Strain characterization of Candida parapsilosis fungemia by molecular typing methods. Eur J Clin Microbiol Infect Dis. 2000, 19 (7): 514-520.CrossRefPubMed
26.
go back to reference Bennett SN, McNeil MM, Bland LA, Arduino MJ, Villarino ME, Perrotta DM, Burwen DR, Welbel SF, Pegues DA, Stroud L, et al: Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med. 1995, 333 (3): 147-154.CrossRefPubMed Bennett SN, McNeil MM, Bland LA, Arduino MJ, Villarino ME, Perrotta DM, Burwen DR, Welbel SF, Pegues DA, Stroud L, et al: Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med. 1995, 333 (3): 147-154.CrossRefPubMed
27.
go back to reference Huang YC, Lin TY, Leu HS, Peng HL, Wu JH, Chang HY: Outbreak of Candida parapsilosis fungemia in neonatal intensive care units: clinical implications and genotyping analysis. Infection. 1999, 27 (2): 97-102.CrossRefPubMed Huang YC, Lin TY, Leu HS, Peng HL, Wu JH, Chang HY: Outbreak of Candida parapsilosis fungemia in neonatal intensive care units: clinical implications and genotyping analysis. Infection. 1999, 27 (2): 97-102.CrossRefPubMed
28.
go back to reference Diekema DJ, Messer SA, Hollis RJ, Wenzel RP, Pfaller MA: An outbreak of Candida parapsilosis prosthetic valve endocarditis. Diagn Microbiol Infect Dis. 1997, 29 (3): 147-153.CrossRefPubMed Diekema DJ, Messer SA, Hollis RJ, Wenzel RP, Pfaller MA: An outbreak of Candida parapsilosis prosthetic valve endocarditis. Diagn Microbiol Infect Dis. 1997, 29 (3): 147-153.CrossRefPubMed
29.
go back to reference Huang YC, Lin TY, Leu HS, Wu JL, Wu JH: Yeast carriage on hands of hospital personnel working in intensive care units. J Hosp Infect. 1998, 39 (1): 47-51.CrossRefPubMed Huang YC, Lin TY, Leu HS, Wu JL, Wu JH: Yeast carriage on hands of hospital personnel working in intensive care units. J Hosp Infect. 1998, 39 (1): 47-51.CrossRefPubMed
30.
go back to reference Leon C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, Leon MA: A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006, 34 (3): 730-737.CrossRefPubMed Leon C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, Leon MA: A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006, 34 (3): 730-737.CrossRefPubMed
31.
go back to reference Chow JK, Golan Y, Ruthazer R, Karchmer AW, Carmeli Y, Lichtenberg DA, Chawla V, Young JA, Hadley S: Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit Care Med. 2008, 36 (7): 1993-1998.CrossRefPubMed Chow JK, Golan Y, Ruthazer R, Karchmer AW, Carmeli Y, Lichtenberg DA, Chawla V, Young JA, Hadley S: Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit Care Med. 2008, 36 (7): 1993-1998.CrossRefPubMed
32.
go back to reference Chow JK, Golan Y, Ruthazer R, Karchmer AW, Carmeli Y, Lichtenberg D, Chawla V, Young J, Hadley S: Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis. 2008, 46 (8): 1206-1213.CrossRefPubMed Chow JK, Golan Y, Ruthazer R, Karchmer AW, Carmeli Y, Lichtenberg D, Chawla V, Young J, Hadley S: Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis. 2008, 46 (8): 1206-1213.CrossRefPubMed
33.
go back to reference Ostrosky-Zeichner L, Sable C, Sobel J, Alexander BD, Donowitz G, Kan V, Kauffman CA, Kett D, Larsen RA, Morrison V, et al: Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis. 2007, 26 (4): 271-276.CrossRefPubMed Ostrosky-Zeichner L, Sable C, Sobel J, Alexander BD, Donowitz G, Kan V, Kauffman CA, Kett D, Larsen RA, Morrison V, et al: Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis. 2007, 26 (4): 271-276.CrossRefPubMed
34.
go back to reference Muskett H, Shahin J, Eyres G, Harvey S, Rowan K, Harrison D: Risk factors for invasive fungal disease in critically ill, adult patients: a systematic review. Crit Care. 2011, 15 (6): R287-CrossRefPubMedPubMedCentral Muskett H, Shahin J, Eyres G, Harvey S, Rowan K, Harrison D: Risk factors for invasive fungal disease in critically ill, adult patients: a systematic review. Crit Care. 2011, 15 (6): R287-CrossRefPubMedPubMedCentral
35.
go back to reference Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, Bearden DT: Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis. 2006, 43 (1): 25-31.CrossRefPubMed Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, Bearden DT: Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis. 2006, 43 (1): 25-31.CrossRefPubMed
36.
go back to reference Morrell M, Fraser VJ, Kollef MH: Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005, 49 (9): 3640-3645.CrossRefPubMedPubMedCentral Morrell M, Fraser VJ, Kollef MH: Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005, 49 (9): 3640-3645.CrossRefPubMedPubMedCentral
37.
go back to reference Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, et al: Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of America. Clin Infect Dis. 2009, 48 (5): 503-535.CrossRefPubMed Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, et al: Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of America. Clin Infect Dis. 2009, 48 (5): 503-535.CrossRefPubMed
38.
go back to reference Horvath EE, Murray CK, Vaughan GM, Chung KK, Hospenthal DR, Wade CE, Holcomb JB, Wolf SE, Mason AD, Cancio LC: Fungal wound infection (not colonization) is independently associated with mortality in burn patients. Ann Surg. 2007, 245 (6): 978-985.CrossRefPubMedPubMedCentral Horvath EE, Murray CK, Vaughan GM, Chung KK, Hospenthal DR, Wade CE, Holcomb JB, Wolf SE, Mason AD, Cancio LC: Fungal wound infection (not colonization) is independently associated with mortality in burn patients. Ann Surg. 2007, 245 (6): 978-985.CrossRefPubMedPubMedCentral
39.
go back to reference Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D: Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003, 37 (9): 1172-1177.CrossRefPubMed Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D: Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003, 37 (9): 1172-1177.CrossRefPubMed
40.
go back to reference Bougnoux ME, Kac G, Aegerter P, D’Enfert C, Fagon JY: Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med. 2008, 34 (2): 292-299.CrossRefPubMed Bougnoux ME, Kac G, Aegerter P, D’Enfert C, Fagon JY: Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med. 2008, 34 (2): 292-299.CrossRefPubMed
41.
go back to reference Tsai CC, Wang CC, Kuo HY, Chiang DH, Lin ML, Liu CY, Yang SP: Adult candidemia at a medical center in northern Taiwan: a retrospective study. J Microbiol Immunol Infect. 2008, 41 (5): 414-421.PubMed Tsai CC, Wang CC, Kuo HY, Chiang DH, Lin ML, Liu CY, Yang SP: Adult candidemia at a medical center in northern Taiwan: a retrospective study. J Microbiol Immunol Infect. 2008, 41 (5): 414-421.PubMed
42.
43.
go back to reference Forrest GN, Weekes E, Johnson JK: Increasing incidence of Candida parapsilosis candidemia with caspofungin usage. J Infect. 2008, 56 (2): 126-129.CrossRefPubMed Forrest GN, Weekes E, Johnson JK: Increasing incidence of Candida parapsilosis candidemia with caspofungin usage. J Infect. 2008, 56 (2): 126-129.CrossRefPubMed
Metadata
Title
A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study
Authors
Su-Pen Yang
Yin-Yin Chen
Han-Shui Hsu
Fu-Der Wang
Liang-yu Chen
Chang-Phone Fung
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-10

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine